Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis.

Blum K, Modestino EJ, Neary J, Gondré-Lewis MC, Siwicki D, Moran M, Hauser M, Braverman ER, Baron D, Steinberg B, Laughlin TM, Badgaiyan RD.

Biomed J Sci Tech Res. 2018 Jan 7;2(2):1-4. doi: 10.26717/BJSTR.2018.02.000738.

2.

Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception.

Laughlin TM, Tram KV, Wilcox GL, Birnbaum AK.

J Pharmacol Exp Ther. 2002 Sep;302(3):1168-75.

PMID:
12183677
3.

Heritability of nociception. III. Genetic relationships among commonly used assays of nociception and hypersensitivity.

Lariviere WR, Wilson SG, Laughlin TM, Kokayeff A, West EE, Adhikari SM, Wan Y, Mogil JS.

Pain. 2002 May;97(1-2):75-86.

PMID:
12031781
4.

Mechanisms of induction of persistent nociception by dynorphin.

Laughlin TM, Larson AA, Wilcox GL.

J Pharmacol Exp Ther. 2001 Oct;299(1):6-11. Review.

PMID:
11561057
5.

Cytokine involvement in dynorphin-induced allodynia.

Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL.

Pain. 2000 Feb;84(2-3):159-67.

PMID:
10666520
6.
7.

Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2.

Stone LS, Fairbanks CA, Laughlin TM, Nguyen HO, Bushy TM, Wessendorf MW, Wilcox GL.

Neuroreport. 1997 Sep 29;8(14):3131-5.

PMID:
9331928
8.

Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors.

Laughlin TM, Vanderah TW, Lashbrook J, Nichols ML, Ossipov M, Porreca F, Wilcox GL.

Pain. 1997 Aug;72(1-2):253-60.

PMID:
9272810
9.

Neurogenesis in postnatal rat spinal cord: a study in primary culture.

Kehl LJ, Fairbanks CA, Laughlin TM, Wilcox GL.

Science. 1997 Apr 25;276(5312):586-9.

Supplemental Content

Loading ...
Support Center